Short answer
Option Care Health, Inc. (OPCH) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.5B (up 4.1% year over year) with net income of $57M.
Q3 2026 key financials · XBRL
- Revenue
- $1.5B
- +4.1% YoY · +3.5% QoQ
- Net income
- $57M
- +10.8% YoY · +6.5% QoQ
- Operating margin
- 6.0%
- Gross margin
- 19.1%
- EPS (diluted)
- $0.38
- +18.8% YoY · +8.6% QoQ
Source: XBRL data from the Option Care Health, Inc. (OPCH) Q3 2026 10-Q on SEC EDGAR. USD.
Option Care Health, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $1,493.5M, up 4.1% from $1,435.0M YoY, driven by acute therapy growth
- Gross margin 19.1% vs 19.0% YoY; operating margin 6.0% vs 5.9%
- Acute therapies best performer, high-single-digit growth; CID weakest, declining from attrition and unfavorable mix
- Operating cash flow $286.2M vs $222.6M; cash $299.1M vs $232.6M at December 31, 2025
- CID headwinds expected to reduce 2026 gross profit by approximately $55M; merger expected to close first half of 2027
Risk Factors
- Newly added merger risk: October 5, 2026 Merger Agreement created approval and closing uncertainties
- Regulatory risk: HSR Act and healthcare regulatory approvals could delay or prevent consummation
- Operational risk: Merger restrictions may limit debt, acquisitions, capital expenditures, and material contracts
- Financial risk: Termination under specified circumstances could require approximately $145.96 million payment
- Legal risk: Stockholder litigation could enjoin or delay the Merger and divert management attention
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Option Care Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.